Investing.com - Biofrontera ADR reported on Monday fourth quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Biofrontera ADR announced earnings per share of $-0.0753 on revenue of $11.29M. Analysts polled by Investing.com anticipated EPS of $-0.0741 on revenue of $11.34M.
Biofrontera ADR shares are down 24.69% from the beginning of the year, still down 88.61% from its 52 week high of $48.20 set on August 5, 2020. They are under-performing the Nasdaq which is up 7.46% from the start of the year.
Biofrontera ADR follows other major sector earnings this month
Biofrontera ADR's report follows an earnings beat by Tencent ADR on March 24, who reported EPS of $0.9354 on revenue of $20.46B, compared to forecasts EPS of $0.5188 on revenue of $20.31B.
Industrial Commercial Bank of China had beat expectations on March 26 with fourth quarter EPS of $0.6708 on revenue of $30.45B, compared to forecast for EPS of $0.5481 on revenue of $31.15B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar